ISSN 2306-5559 (print)
ISSN 2410-938X (online)
ISSN 2410-938X (online)
The authors declare no conflicts of interest.
1. Feske SK. Ischemic Stroke. Am J Med. 2021;134(12):1457-1464. doi:10.1016/j.amjmed.2021.07.027.2. Sarmah D, Datta A, Raut S, et al. The Role of Inflammasomes in Atherosclerosis and Stroke Pathogenesis. Curr Pharm Des. 2020;26(34):4234-4245. doi:10.2174/13816128266662004270849493. Gusev E, Sarapultsev A. Atherosclerosis and Inflammation: Insights from the Theory of General Pathological Processes. Int J Mol Sci. 2023;24(9):7910. Published 2023 Apr 26. doi:10.3390/ijms240979104. Yoshida K, Miyamoto S. Evidence for management of carotid artery stenosis. Neurol Med Chir (Tokyo). 2015;55(3):230-240. doi:10.2176/nmc.ra.2014-03615. Saini V, Guada L, Yavagal DR. Global Epidemiology of Stroke and Access to Acute Ischemic Stroke Interventions. Neurology. 2021;97(20 Suppl 2):S6-S16. doi:10.1212/WNL.00000000000127816. Global Burden of Disease Study 2016. Global Burden of Disease Study 2016 (GBD 2016) results. Seattle, WA: Institute for Health Metrics and Evaluation (IHME), University of Washington; 20167. Krishnamurthi RV, Feigin VL, Forouzanfar MH, et al. Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet Glob Health. 2013;1(5):e259-e281. doi:10.1016/S2214-109X(13)70089-58. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.published correction appears in Lancet. 2013 Feb 23;381(9867):628. AlMazroa, Mohammad A.added]; Memish, Ziad A.added] Lancet. 2012;380(9859):2095-2128. doi:10.1016/S0140-6736(12)61728-09. Bokerija L.A., Gudkova R.G. Serdechno-sosudistaja hirurgija. 2010; Bolezni i vrozhdennye anomalii sistemy krovoobrashhenija. M.: NCSSH im. A.N. Bakuleva RAMN. 2011; 19210. Suslina ZA, Piradov MA, Domashenko MA. Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(11):5-13.11. Zhusupova AS, Alzhanova DS, Nurmanova ShA SB, Dzhumahayeva AS, Altayeva BS. Modern strategy of medical care to patients with stroke. Neurosurg. Neurol. Kazakhstan. 2013;30:32-512. Zhakhina G, Zhalmagambetov B, Gusmanov A, et al. Incidence and mortality rates of strokes in Kazakhstan in 2014-2019. Sci Rep. 2022;12(1):16041. Published 2022 Sep 26. doi:10.1038/s41598-022-20302-813. Agency for Healthcare Research and Quality. Total expenditures in millions by condition, United States, 1996–2015: Medical Expenditure Panel Survey14. RTI International. Projections of cardiovascular disease prevalence and costs: 2015–2035. Research Triangle Park, NC: RTI International;2016. RTI project number 021480.003.001.001.15. Godwin KM, Wasserman J, Ostwald SK. Cost associated with stroke: outpatient rehabilitative services and medication. Top Stroke Rehabil. 2011;18 Suppl 1:676-684. doi:10.1310/tsr18s01-67616. World Health Organization. Equity, social determinants and public health programmes. Geneva, WHO, 201017. Everson-Rose SA, Roetker NS, Lutsey PL, et al. Chronic stress, depressive symptoms, anger, hostility, and risk of stroke and transient ischemic attack in the multi-ethnic study of atherosclerosis. Stroke. 2014;45(8):2318-2323. doi:10.1161/STROKEAHA.114.00481518. Eshak ES, Honjo K, Iso H, et al. Changes in the Employment Status and Risk of Stroke and Stroke Types. Stroke. 2017;48(5):1176-1182. doi:10.1161/STROKEAHA.117.01696719. Kivimäki M, Jokela M, Nyberg ST, et al. Long working hours and risk of coronary heart disease and stroke: a systematic review and meta-analysis of published and unpublished data for 603,838 individuals. Lancet. 2015;386(10005):1739-1746. doi:10.1016/S0140-6736(15)60295-120. Nagayoshi M, Everson-Rose SA, Iso H, Mosley TH Jr, Rose KM, Lutsey PL. Social network, social support, and risk of incident stroke: Atherosclerosis Risk in Communities study. Stroke. 2014;45(10):2868-2873. doi:10.1161/STROKEAHA.114.00581521. Mohan KM, Wolfe CD, Rudd AG, Heuschmann PU, Kolominsky-Rabas PL, Grieve AP. Risk and cumulative risk of stroke recurrence: a systematic review and meta-analysis. Stroke. 2011;42(5):1489-1494. doi:10.1161/STROKEAHA.110.60261522. Callaly E, Ni Chroinin D, Hannon N, et al. Rates, Predictors, and Outcomes of Early and Late Recurrence After Stroke: The North Dublin Population Stroke Study. Stroke. 2016;47(1):244-246. doi:10.1161/STROKEAHA.115.01124823. Pennlert J, Eriksson M, Carlberg B, Wiklund PG. Long-term risk and predictors of recurrent stroke beyond the acute phase. Stroke. 2014;45(6):1839-1841. doi:10.1161/STROKEAHA.114.00506024. Howard G, Kissela BM, Kleindorfer DO, et al. Differences in the role of black race and stroke risk factors for first vs. recurrent stroke. Neurology. 2016;86(7):637-642. doi:10.1212/WNL.000000000000237625. Writing Group Members, Mozaffarian D, Benjamin EJ, et al. Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association.published correction appears in Circulation. 2016 Apr 12;133(15):e599. doi: 10.1161/CIR.0000000000000409 Circulation. 2016;133(4):e38-e360. doi:10.1161/CIR.000000000000035026. Arnalich-Montiel A, Burgos-Santamaría A, Pazó-Sayós L, Quintana-Villamandos B. Comprehensive Management of Stroke: From Mechanisms to Therapeutic Approaches. Int J Mol Sci. 2024;25(10):5252. Published 2024 May 11. doi:10.3390/ijms2510525227. Reinhard M, Schwarzer G, Briel M, et al. Cerebrovascular reactivity predicts stroke in high-grade carotid artery disease. Neurology. 2014;83(16):1424-1431. doi:10.1212/WNL.0000000000000888z28. Zheng B, Luo Y, Li Y, et al. Prevalence and risk factors of stroke in high-altitude areas: a systematic review and meta-analysis. BMJ Open. 2023;13(9):e071433. Published 2023 Sep 21. doi:10.1136/bmjopen-2022-07143329. Koton S, Pike JR, Johansen M, et al. Association of Ischemic Stroke Incidence, Severity, and Recurrence With Dementia in the Atherosclerosis Risk in Communities Cohort Study. JAMA Neurol. 2022;79(3):271-280. doi:10.1001/jamaneurol.2021.508030. Libby P. The changing landscape of atherosclerosis. Nature. 2021;592(7855):524-533. doi:10.1038/s41586-021-03392-831. Chow YL, Teh LK, Chyi LH, Lim LF, Yee CC, Wei LK. Lipid Metabolism Genes in Stroke Pathogenesis: The Atherosclerosis. Curr Pharm Des. 2020;26(34):4261-4271. doi:10.2174/138161282666620061418095832. Kong P, Cui ZY, Huang XF, Zhang DD, Guo RJ, Han M. Inflammation and atherosclerosis: signaling pathways and therapeutic intervention. Signal Transduct Target Ther. 2022;7(1):131. Published 2022 Apr 22. doi:10.1038/s41392-022-00955-733. Zhu Y, Xian X, Wang Z, et al. Research Progress on the Relationship between Atherosclerosis and Inflammation. Biomolecules. 2018;8(3):80. Published 2018 Aug 23. doi:10.3390/biom803008034. Bäck M, Yurdagul A Jr, Tabas I, Öörni K, Kovanen PT. Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities. Nat Rev Cardiol. 2019;16(7):389-406. doi:10.1038/s41569-019-0169-235. von Vietinghoff S, Koltsova EK. Inflammation in atherosclerosis: A key role for cytokines. Cytokine. 2019;122:154819. doi:10.1016/j.cyto.2019.15481936. Wolfs IM, Donners MM, de Winther MP. Differentiation factors and cytokines in the atherosclerotic plaque micro-environment as a trigger for macrophage polarisation. Thromb Haemost. 2011;106(5):763-771. doi:10.1160/TH11-05-032037. He C, Kim HI, Park J, Guo J, Huang W. The role of immune cells in different stages of atherosclerosis. Int J Med Sci. 2024;21(6):1129-1143. Published 2024 Apr 22. doi:10.7150/ijms.9457038. Hermansson A, Ketelhuth DF, Strodthoff D, et al. Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosis. J Exp Med. 2010;207(5):1081-1093. doi:10.1084/jem.2009224339. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet. 1998;351(9113):1379-1387.40. Oliveira TF, Centellas CDR, Dalio MB, Joviliano EE. Short term outcomes of carotid surgery: the real-world experience of a single teaching center. J Vasc Bras. 2024;23:e20230033. Published 2024 Feb 5. doi:10.1590/1677-5449.20230033241. Ferrero E, Ferri M, Viazzo A, et al. A retrospective study on early carotid endarterectomy within 48 hours after transient ischemic attack and stroke in evolution. Ann Vasc Surg. 2014;28(1):227-238. doi:10.1016/j.avsg.2013.02.01542. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation. 2014;129(3):e28-e292. doi:10.1161/01.cir.0000441139.02102.8043. Wang FW, Esterbrooks D, Kuo YF, Mooss A, Mohiuddin SM, Uretsky BF. Outcomes after carotid artery stenting and endarterectomy in the Medicare population. Stroke. 2011;42(7):2019-2025. doi:10.1161/STROKEAHA.110.60899244. Jalbert JJ, Nguyen LL, Gerhard-Herman MD, et al. Comparative Effectiveness of Carotid Artery Stenting Versus Carotid Endarterectomy Among Medicare Beneficiaries. Circ Cardiovasc Qual Outcomes. 2016;9(3):275-285. doi:10.1161/CIRCOUTCOMES.115.00233645. Kim LK, Yang DC, Swaminathan RV, et al. Comparison of trends and outcomes of carotid artery stenting and endarterectomy in the United States, 2001 to 2010. Circ Cardiovasc Interv. 2014;7(5):692-700. doi:10.1161/CIRCINTERVENTIONS.113.00133846. Al-Damluji MS, Dharmarajan K, Zhang W, et al. Readmissions after carotid artery revascularization in the Medicare population. J Am Coll Cardiol. 2015;65(14):1398-1408. doi:10.1016/j.jacc.2015.01.04847. Bangalore S, Bhatt DL, Röther J, et al. Late outcomes after carotid artery stenting versus carotid endarterectomy: insights from a propensity-matched analysis of the Reduction of Atherothrombosis for Continued Health (REACH) Registry. Circulation. 2010;122(11):1091-1100. doi:10.1161/CIRCULATIONAHA.109.93334148. Vilain KR, Magnuson EA, Li H, et al. Costs and cost-effectiveness of carotid stenting versus endarterectomy for patients at standard surgical risk: results from the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST). Stroke. 2012;43(9):2408-2416. doi:10.1161/STROKEAHA.112.66135549. Witt AH, Johnsen SP, Jensen LP, Hansen AK, Hundborg HH, Andersen G. Reducing delay of carotid endarterectomy in acute ischemic stroke patients: a nationwide initiative. Stroke. 2013;44(3):686-690. doi:10.1161/STROKEAHA.111.67856550. Mokin M, Rojas H, Levy EI. Randomized trials of endovascular therapy for stroke--impact on stroke care. Nat Rev Neurol. 2016;12(2):86-94. doi:10.1038/nrneurol.2015.24051. von Kummer R, Bourquain H, Bastianello S, et al. Early prediction of irreversible brain damage after ischemic stroke at CT. Radiology. 2001;219(1):95-100. doi:10.1148/radiology.219.1.r01ap069552. Slater JP, Guarino T, Stack J, et al. Cerebral oxygen desaturation predicts cognitive decline and longer hospital stay after cardiac surgery. Ann Thorac Surg. 2009;87(1):36-45. doi:10.1016/j.athoracsur.2008.08.07053. Lal BK, Beach KW, Roubin GS, et al. Restenosis after carotid artery stenting and endarterectomy: a secondary analysis of CREST, a randomised controlled trial. Lancet Neurol. 2012;11(9):755-763. doi:10.1016/S1474-4422(12)70159-X54. Ricotta JJ, Aburahma A, Ascher E, et al. Updated Society for Vascular Surgery guidelines for management of extracranial carotid disease.published correction appears in J Vasc Surg. 2012 Mar;55(3):894 J Vasc Surg. 2011;54(3):e1-e31. doi:10.1016/j.jvs.2011.07.03155. Grotta JC. Clinical practice. Carotid stenosis. N Engl J Med. 2013;369(12):1143-1150. doi:10.1056/NEJMcp121499956. Singh RJ, Chen S, Ganesh A, Hill MD. Long-term neurological, vascular, and mortality outcomes after stroke. Int J Stroke. 2018;13(8):787-796. doi:10.1177/174749301879852657. Moran AE, Roth GA, Narula J, Mensah GA. 1990-2010 global cardiovascular disease atlas. Glob Heart. 2014;9(1):3-16. doi:10.1016/j.gheart.2014.03.122058. Caplan LR, Wityk RJ, Glass TA, et al. New England Medical Center Posterior Circulation registry. Ann Neurol. 2004;56(3):389-398. doi:10.1002/ana.2020459. Flossmann E, Rothwell PM. Prognosis of vertebrobasilar transient ischaemic attack and minor stroke. Brain. 2003;126(Pt 9):1940-1954. doi:10.1093/brain/awg19760. Shutze W, Gierman J, McQuade K, Pearl G, Smith B. Treatment of proximal vertebral artery disease. Vascular. 2014;22(2):85-92. doi:10.1177/170853811247396661. Blacker DJ, Flemming KD, Wijdicks EF. Risk of ischemic stroke in patients with symptomatic vertebrobasilar stenosis undergoing surgical procedures. Stroke. 2003;34(11):2659-2663. doi:10.1161/01.STR.0000092120.03676.D662. Amin-Hanjani S, Stapleton CJ, Du X, et al. Hypoperfusion Symptoms Poorly Predict Hemodynamic Compromise and Stroke Risk in Vertebrobasilar Disease. Stroke. 2019;50(2):495-497. doi:10.1161/STROKEAHA.118.02310163. Zhao K, Yan P, Wang X, et al. A retrospective study of drug-coated balloon angioplasty for vertebral artery origin stenosis. Neuroradiology. 2022;64(8):1617-1625. doi:10.1007/s00234-022-02926-964. Weber W, Mayer TE, Henkes H, et al. Efficacy of stent angioplasty for symptomatic stenoses of the proximal vertebral artery. Eur J Radiol. 2005;56(2):240-247. doi:10.1016/j.ejrad.2005.05.00965. Xu R, Zhang X, Liu S, et al. Percutaneous transluminal angioplasty and stenting for vertebral artery stenosis. Cochrane Database Syst Rev. 2022;5(5):CD013692. Published 2022 May 17. doi:10.1002/14651858.CD013692.pub266. Burle VS, Panjwani A, Mandalaneni K, Kollu S, Gorantla VR. Vertebral Artery Stenosis: A Narrative Review. Cureus. 2022;14(8):e28068. Published 2022 Aug 16. doi:10.7759/cureus.2806867. Eberhardt O, Naegele T, Raygrotzki S, Weller M, Ernemann U. Stenting of vertebrobasilar arteries in symptomatic atherosclerotic disease and acute occlusion: case series and review of the literature. J Vasc Surg. 2006;43(6):1145-1154. doi:10.1016/j.jvs.2006.02.02768. Gulli G, Marquardt L, Rothwell PM, Markus HS. Stroke risk after posterior circulation stroke/transient ischemic attack and its relationship to site of vertebrobasilar stenosis: pooled data analysis from prospective studies. Stroke. 2013;44(3):598-604. doi:10.1161/STROKEAHA.112.66992969. Coward LJ, McCabe DJ, Ederle J, et al. Long-term outcome after angioplasty and stenting for symptomatic vertebral artery stenosis compared with medical treatment in the Carotid And Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomized trial. Stroke. 2007;38(5):1526-1530. doi:10.1161/STROKEAHA.106.47186270. Compter A, van der Worp HB, Schonewille WJ, et al. Stenting versus medical treatment in patients with symptomatic vertebral artery stenosis: a randomised open-label phase 2 trial. Lancet Neurol. 2015;14(6):606-614. doi:10.1016/S1474-4422(15)00017-471. Chimowitz MI, Lynn MJ, Derdeyn CP, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis.published correction appears in N Engl J Med. 2012 Jul 5;367(1):93 N Engl J Med. 2011;365(11):993-1003. doi:10.1056/NEJMoa110533572. Fiorella D, Derdeyn CP, Lynn MJ, et al. Detailed analysis of periprocedural strokes in patients undergoing intracranial stenting in Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS). Stroke. 2012;43(10):2682-2688. doi:10.1161/STROKEAHA.112.66117373. Feng H, Xie Y, Mei B, et al. Endovascular vs. medical therapy in symptomatic vertebral artery stenosis: a meta-analysis. J Neurol. 2017;264(5):829-838. doi:10.1007/s00415-016-8267-074. Markus HS, Larsson SC, Kuker W, et al. Stenting for symptomatic vertebral artery stenosis: The Vertebral Artery Ischaemia Stenting Trial. Neurology. 2017;89(12):1229-1236. doi:10.1212/WNL.000000000000438575. Markus HS, Harshfield EL, Compter A, et al. Stenting for symptomatic vertebral artery stenosis: a preplanned pooled individual patient data analysis. Lancet Neurol. 2019;18(7):666-673. doi:10.1016/S1474-4422(19)30149-876. Tedgui A, Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev. 2006;86(2):515-581. doi:10.1152/physrev.00024.200577. Halliday A, Harrison M, Hayter E, et al. 10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial. Lancet. 2010;376(9746):1074-1084. doi:10.1016/S0140-6736(10)61197-X78. Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA. 1995;273(18):1421-1428.79. North American Symptomatic Carotid Endarterectomy Trial Collaborators, Barnett HJM, Taylor DW, et al. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991;325(7):445-453. doi:10.1056/NEJM19910815325070180. Naylor AR, Sayers RD, McCarthy MJ, et al. Closing the loop: a 21-year audit of strategies for preventing stroke and death following carotid endarterectomy. Eur J Vasc Endovasc Surg. 2013;46(2):161-170. doi:10.1016/j.ejvs.2013.05.00581. Rockman CB, Halm EA. Intraoperative imaging: does it really improve perioperative outcomes of carotid endarterectomy?. Semin Vasc Surg. 2007;20(4):236-243. doi:10.1053/j.semvascsurg.2007.10.00382. Naylor AR, Sayers RD, McCarthy MJ, et al. Closing the loop: a 21-year audit of strategies for preventing stroke and death following carotid endarterectomy. Eur J Vasc Endovasc Surg. 2013;46(2):161-170. doi:10.1016/j.ejvs.2013.05.00583. Letsou GV, Musfee FI, Zhang Q, Loor G, Lee AD. Stroke and mortality rates after off-pump vs. pump-assisted/no-clamp coronary artery bypass grafting. J Cardiovasc Surg (Torino). 2022;63(6):742-748. doi:10.23736/S0021-9509.22.12337-284. Ricco JB, Forbes TL. Trans-atlantic debate: the role of completion imaging following carotid artery endarterectomy. Eur J Vasc Endovasc Surg. 2013;45(5):415. doi:10.1016/j.ejvs.2013.02.00585. Jacobsen AP, Raber I, McCarthy CP, et al. Lifelong Aspirin for All in the Secondary Prevention of Chronic Coronary Syndrome: Still Sacrosanct or Is Reappraisal Warranted?. Circulation. 2020;142(16):1579-1590. doi:10.1161/CIRCULATIONAHA.120.04569586. Gutzwiller F. Monitoring of cardiovascular disease and risk factor trends: experiences from the WHO/MONICA project. Ann Med. 1994;26(1):61-65. doi:10.3109/07853899409147329